Kim M Linton, Umberto Vitolo, Wojciech Jurczak, P. Lugtenburg, E. Gyan, Anna Sureda, J. H. Christensen, Brian Hess, Hervé Tilly, Raúl Córdoba, David John Lewis, Craig Okada, Martin Hutchings, M. Clausen, J. Sancho, Tara Cochrane, S. Leppä, M. Chamuleau, Diana Gernhardt, I. Altıntaş, Yan Liu, Tahamtan Ahmadi, Minh H Dinh, Daniela Hoehn, Elena Favaro, B. Elliott, C. Thieblemont, Julie M Vose
{"title":"复发性或难治性滤泡性淋巴瘤患者的埃博瑞他单抗单药治疗(EPCORE NHL-1):单臂多中心研究的第二阶段队列","authors":"Kim M Linton, Umberto Vitolo, Wojciech Jurczak, P. Lugtenburg, E. Gyan, Anna Sureda, J. H. Christensen, Brian Hess, Hervé Tilly, Raúl Córdoba, David John Lewis, Craig Okada, Martin Hutchings, M. Clausen, J. Sancho, Tara Cochrane, S. Leppä, M. Chamuleau, Diana Gernhardt, I. Altıntaş, Yan Liu, Tahamtan Ahmadi, Minh H Dinh, Daniela Hoehn, Elena Favaro, B. Elliott, C. Thieblemont, Julie M Vose","doi":"10.1016/s2352-3026(24)00166-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":118760,"journal":{"name":"The Lancet Haematology","volume":"163 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study\",\"authors\":\"Kim M Linton, Umberto Vitolo, Wojciech Jurczak, P. Lugtenburg, E. Gyan, Anna Sureda, J. H. Christensen, Brian Hess, Hervé Tilly, Raúl Córdoba, David John Lewis, Craig Okada, Martin Hutchings, M. Clausen, J. Sancho, Tara Cochrane, S. Leppä, M. Chamuleau, Diana Gernhardt, I. Altıntaş, Yan Liu, Tahamtan Ahmadi, Minh H Dinh, Daniela Hoehn, Elena Favaro, B. Elliott, C. Thieblemont, Julie M Vose\",\"doi\":\"10.1016/s2352-3026(24)00166-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":118760,\"journal\":{\"name\":\"The Lancet Haematology\",\"volume\":\"163 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Haematology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/s2352-3026(24)00166-2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Haematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2352-3026(24)00166-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study